EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Neoehrlichiosis Causing Hemolytic Anemia in Patients Treated with Rituximab, Norway, 2024–2025

Martin Paulson, Christine Wennerås, Hanne Quarsten, Kristine K Berg, Anders L Drivenes, Magnus Moksnes, Tor Henrik A Tvedt

Emerging Infectious Diseases · 2026-09 · 32 (9) · 1391-1396

DOI: 10.3201/eid3209.260553 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Emerging Infectious Diseases, 2026-09. Verfasst von Martin Paulson und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Anaplasmataceae, Anaplasmataceae Infections, Anemia, Hemolytic, Rituximab. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnaplasmataceaeAnaplasmataceae InfectionsAnemia, HemolyticRituximabHumansAnti-Bacterial AgentsNorway

Stichwörter der Autor:innen

AnaplasmataceaeNeoehrlichia mikurensisNorwaybacteriabacterial infectionshemolytic anemiaimmunocompromised patientsneoehrlichiosisrituximabsplenomegalytickborne diseasesvector-borne infections

Substanzen

Anti-Bacterial AgentsRituximab

Zitieren

APA

Paulson, M., Wennerås, C., Quarsten, H., Berg, K. K., Drivenes, A. L., Moksnes, M., & Tvedt, T. H. A. (2026). Neoehrlichiosis Causing Hemolytic Anemia in Patients Treated with Rituximab, Norway, 2024–2025. Emerging Infectious Diseases, 32(9), 1391-1396. https://doi.org/10.3201/eid3209.260553

Vancouver

Paulson M, Wennerås C, Quarsten H, Berg KK, Drivenes AL, Moksnes M, et al. Neoehrlichiosis Causing Hemolytic Anemia in Patients Treated with Rituximab, Norway, 2024–2025. Emerging Infectious Diseases. 2026;32(9):1391-1396. doi:10.3201/eid3209.260553

BibTeX
@article{Paulson2026,
  author = {Paulson, Martin and Wennerås, Christine and Quarsten, Hanne and Berg, Kristine K and Drivenes, Anders L and Moksnes, Magnus and Tvedt, Tor Henrik A},
  title = {Neoehrlichiosis Causing Hemolytic Anemia in Patients Treated with Rituximab, Norway, 2024–2025},
  journal = {Emerging Infectious Diseases},
  year = {2026},
  volume = {32},
  number = {9},
  pages = {1391--1396},
  doi = {10.3201/eid3209.260553}
}
Kostenlos starten →